Resultados de la búsqueda 181-190 of 10205 for Cycle

  1. Hematología - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles ... cycles of mosunetuzumab. An ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles ... cycles of mosunetuzumab. An ...

  3. Neurocirugía - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  4. Hematología - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  7. Neurocirugía - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  8. Hematología - Ensayos clínicos

    ... cycle, if necessary delayed until all clinical parameters are acceptable to proceed with the next planned cycle of therapy; (3) if patient is completing non ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) ... All participants who have completed the first course of pembrolizumab may be ...